Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, announced today that it has donated nearly $300,000 in medication to Health Partners International of Canada (HPIC). The medication is destined for Nicaragua, one of the poorest countries in Latin America. This is vital support for HPIC's mission of improving the health of people in developing nations.
